Drug Type Small molecule drug |
Synonyms casein kinase 2 alpha/sirtuin-1 deacetylase pathway regulators (Bioway Inc), BWL-211 |
Target |
Action inhibitors, stimulants |
Mechanism CSNK2A1 inhibitors(casein kinase 2 alpha 1 inhibitors), SIRT1 stimulants(NAD-dependent deacetylase sirtuin 1 stimulants), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nonalcoholic Steatohepatitis | Discovery | South Korea | - |





